Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mothersill, C.
Right arrow Articles by O'Malley, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mothersill, C.
Right arrow Articles by O'Malley, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 9, 1465-1471, September 2001
© 2001 Oxford University Press


CARCINOGENESIS

Individual variation in the production of a `bystander signal' following irradiation of primary cultures of normal human urothelium

Carmel Mothersill1,4, David Rea3, Eric G. Wright2, Sally A. Lorimore2, Dennis Murphy3, Colin B. Seymour1 and Kiaran O'Malley3

1 Radiation and Environmental Science Centre, Dublin Institute of Technology, Kevin Street, Dublin 8, Republic of Ireland,
2 Department of Cell Pathology, Ninewells Hospital Medical School, Dundee, Scotland, UK and
3 Department of Urology, Beaumont Hospital, Dublin 9, Republic of Ireland

The existence of a bystander effect following both alpha and gamma irradiation of many cell lines is not now in dispute. The significance of this effect for cancer risk assessment and radiotherapy treatment planning requires demonstration of its relevance in vivo. The problem in demonstrating the existence of the effect in vivo is that other systemic effects may mask or confound the effect being investigated and it is practically impossible to attribute an effect in a particular cell to a signal produced in another irradiated cell. To approach this problem, we have developed an assay where fragments of human tissue can be irradiated ex vivo and the media harvested and added to unirradiated, allogenic explants or to a clonogenic cell line which has a well characterized and stable response to the bystander signal. The variation in production of the signal from patient to patient can thus be assessed using molecular and cellular endpoints. A study using tissue from over 100 patients and from mouse strains with well characterized responses to low level radiation exposure shows that there is variation in the effect of the signal produced by irradiated tissue from different patients. Gender, smoking status and the existence of a bladder malignancy influence the expression of the signal by normal urothelium. The effects of exposure to medium containing the signal are transmitted to distant progeny of the exposed cell population. The results may be important not only for understanding radiation risk mechanisms for protection but also for radiotherapy treatment planning where they may open new avenues for development of drugs for combined therapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
C Mothersill, M J Moriarty, and C B Seymour
Bystander and other delayed effects and multi-organ involvement and failure following high dose exposure to ionising radiation
Br. J. Radiol., January 1, 2005; Supplement_27(1): 128 - 131.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
E. G Wright
Commentary on radiation-induced bystander effects
Human and Experimental Toxicology, February 1, 2004; 23(2): 91 - 94.
[Abstract] [PDF]


Home page
JNMHome page
G. Akabani, S. J. Kennel, and M. R. Zalutsky
Microdosimetric Analysis of {alpha}-Particle-Emitting Targeted Radiotherapeutics Using Histological Images
J. Nucl. Med., May 1, 2003; 44(5): 792 - 805.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.